Wikiwand AI

3-Thiosymbescaline

Pharmaceutical compound From Wikipedia, the free encyclopedia

3-Thiosymbescaline (3-TSB), also known as 3-ethylthio-4-methoxy-5-ethoxyphenethylamine, is a chemical compound of the phenethylamine and scaline families related to mescaline.[1][2][3][4] It is the analogue of symbescaline in which the ethoxy group at the 3 position has been replaced with an ethylthio group.[1][2][3][4] The compound is one of two possible thiosymbescaline (TSB) positional isomers, the other being 4-thiosymbescaline (4-TSB).[1][2][3][4]

Other names3-TSB; 3-Ethylthio-4-methoxy-5-ethoxyphenethylamine; 3-EtS-4-MeO-5-EtO-PEA
ATC code
  • None
Quick facts Clinical data, Other names ...
3-Thiosymbescaline
Clinical data
Other names3-TSB; 3-Ethylthio-4-methoxy-5-ethoxyphenethylamine; 3-EtS-4-MeO-5-EtO-PEA
Routes of
administration
Oral[1]
ATC code
  • None
Pharmacokinetic data
Duration of actionUnknown[1]
Identifiers
  • 2-(3-ethoxy-5-ethylsulfanyl-4-methoxyphenyl)ethanamine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC13H21NO2S
Molar mass255.38 g·mol−1
3D model (JSmol)
  • CCOC1=C(C(=CC(=C1)CCN)SCC)OC
  • InChI=1S/C13H21NO2S/c1-4-16-11-8-10(6-7-14)9-12(17-5-2)13(11)15-3/h8-9H,4-7,14H2,1-3H3
  • Key:BTJFGKUKBHSKHI-UHFFFAOYSA-N
Close

In his book PiHKAL (Phenethylamines I Have Known and Loved) and other publications, Alexander Shulgin lists 3-TSB's dose as greater than 200 mg orally and its duration as unknown.[1][2][3] The compound produced no effects whatsoever at a dose of up to 200 mg orally.[1]

The chemical synthesis of 3-TSB has been described.[1][4]

3-TSB was first described in the scientific literature by Shulgin and Peyton Jacob III in 1984.[4] Subsequently, it was described in greater detail by Shulgin in PiHKAL in 1991.[1]

See also

References

Related Articles

Timelines

Top Qs

Fact Checks